Actifuse Granules key features:
Silicate substitution changes the surface charge of the material attracting more of the proteins that bind osteoblasts (bone-forming cells). This accelerates bone formation
Optimised structure with interconnected porosity encourages and supports rapid bone formation
Actifuse resorption is cell mediated and avoids a biological race between graft dissolution and new bone formation. This minimises the risk of a foreign body response to particulate debris observed with some synthetic materials
In vitro and in vivo data demonstrate that Actifuse enhances each of the key steps in bone formation and can produce more high quality bone, more rapidly than other synthetic materials.
Actifuse. More bone, less time
2-5mm granules for large graft areas
The unique granular structure of Actifuse, when combined with localized blood or in combination with blood marrow aspirate, in a ration of 1-1.5:1 (blood/BMA to Actifuse) allows for optimal handling and placement characteristics.
Cohesive graft when mixed with blood or bone marrow aspirate
 |
 |
Order information:
| Product Code |
Granule Size |
Pack Size |
| 506005078028 | 2-5mm |
5ml |
| 506005078029 |
2-5mm | 10ml |
| 506005078030 | 2-5mm | 20ml |
| 506005078056 | 2-5mm | 30ml |
Indications for Use: United States
Actifuse is a bone void filler intended only for orthopaedic applications as a filler for gaps and voids that are not intrinsic to the stability of the bony structure. Actifuse is indicated to be packed gently into bony voids or gaps of the skeletal system, i.e., extremities, pelvis, and spine. These defects may be surgically created osseous defects or osseous defects created from traumatic injury to the bone. The product provides a bone void filler that resorbs and is replaced by bone during the healing process.TOP
Caution: Federal (US) law restricts this device to sale by or on the order of a physician.
